Heron Therapeutics Inc
NASDAQ:HRTX

Watchlist Manager
Heron Therapeutics Inc Logo
Heron Therapeutics Inc
NASDAQ:HRTX
Watchlist
Price: 1.28 USD Market Closed
Market Cap: 234.7m USD

Wall Street
Price Targets

HRTX Price Targets Summary
Heron Therapeutics Inc

Wall Street analysts forecast HRTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HRTX is 4.59 USD with a low forecast of 3.03 USD and a high forecast of 6.3 USD.

Lowest
Price Target
3.03 USD
137% Upside
Average
Price Target
4.59 USD
259% Upside
Highest
Price Target
6.3 USD
392% Upside
Heron Therapeutics Inc Competitors:
Price Targets
LVTX
LAVA Therapeutics NV
20% Downside
IMDX
Insight Molecular Diagnostics Inc
12% Upside
ARQT
Arcutis Biotherapeutics Inc
11% Upside
002007
Hualan Biological Engineering Inc
25% Upside
TECX
AVROBIO Inc
290% Upside
6855
Ascentage Pharma Group International
90% Upside
OPK
OPKO Health Inc
190% Upside
PHARM
Pharming Group NV
45% Upside

Revenue
Forecast

Revenue Estimate
Heron Therapeutics Inc

For the last 13 years the compound annual growth rate for Heron Therapeutics Inc's revenue is 52%. The projected CAGR for the next 4 years is 14%.

52%
Past Growth
14%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Heron Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
Heron Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-58%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HRTX's stock price target?
Price Target
4.59 USD

According to Wall Street analysts, the average 1-year price target for HRTX is 4.59 USD with a low forecast of 3.03 USD and a high forecast of 6.3 USD.

What is Heron Therapeutics Inc's Revenue forecast?
Projected CAGR
14%

For the last 13 years the compound annual growth rate for Heron Therapeutics Inc's revenue is 52%. The projected CAGR for the next 4 years is 14%.

Back to Top